Vericel

0 followers

‌

Vericel (NASDAQ:VCEL) develops, manufactures and markets autologous expanded cell therapies for the treatment of patients with serious diseases and conditions

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

51-200

Links

Org chart

Dominick Colangelo

President & CEO

Dominick Colangelo

Collapse

Joe Mara

CFO

Jonathan Hopper

Chief Medical Officer

Sean Flynn

SVP, General Counsel & Secretary

Mike Halpin

SVP, Quality & Regulatory Affairs

Patrick Fowler

SVP, Corporate Development & Strategy

Roland DeAngelis

SVP, Commercial Operations

Doug Kennedy

SVP, Operations

Heidi Hassen

SVP, Human Resources

Shannon Kelly

VP, Burn Care National Sales

Caryn Crame

VP, Clinical Affairs & Epidemiology

VP, MACI Sales

VP, Manufacturing

VP, Quality

VP, Marketing & Commercial Strategy

Teams

+28

Sales and Marketing

31 members

+12

Clinical and Medical Affairs

15 members

Operations and Development Team

12 members

Quality and Regulatory

9 members

Directors Team

9 members

Finance and Accounting

8 members

Similar companies

Summit Therapeutics

4 followers

4D Molecular Therapeutics

3 followers

Pivot Bio

2 followers

Matica Biotechnology

1 follower

Thermo Fisher Scientific

166 followers

Kura Oncology

17 followers

Exact Sciences

15 followers

CRISPR Therapeutics

10 followers

United Therapeutics

7 followers

Transnetyx

1 follower

Kippa

53 followers

Explore companies